Excitation of a Single Compound by Light and Ultrasound Enhanced the Long-Term Cure of Mice Bearing Prostate Tumors
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms241310624 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Joseph Cacaccio und 9 weiteren Autor:innen. Beteiligte Einrichtung: PDT Center, Cell Stress Biology, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263, USA. Hauptthemen laut MEDLINE: Photochemotherapy, Prostatic Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, RPCCC Support Grant, Photolitec, LLC.
Abstract (Originalsprache)
Current treatment for prostate cancer is dependent on the stages of the cancer, recurrence, and genetic factors. Treatment varies from active surveillance or watchful waiting to prostatectomy, chemotherapy, and radiation therapy in combination or alone. Although radical prostate cancer therapy reduces the advancement of the disease and its mortality, the increased disease treatment associated morbidity, erectile dysfunction, and incontinence affect the quality of life of cancer survivors. To overcome these problems, photodynamic therapy (PDT) has previously been investigated using PhotofrinTM as a photosensitizer (PS). However, Photofrin-PDT has shown limitations in treating prostate cancer due to its limited tumor-specificity and the depth of light penetration at 630 nm (the longest wavelength absorption of PhotofrinTM). The results presented herein show that this limitation can be solved by using a near infrared (NIR) compound as a photosensitizer (PS) for PDT and the same agent also acts as a sonosensitizer for SDT (using ultrasound to activate the compound). Compared to light, ultrasound has a stronger penetration ability in biological tissues. Exposing the PS (or sonosensitizer) to ultrasound (US) initiates an electron-transfer process with a biological substrate to form radicals and radical ions (type I reaction). In contrast, exposure of the PS to light (PDT) generates singlet oxygen (type II reaction). Therefore, the reactive oxygen species (ROS) produced by SDT and PDT follow two distinct pathways, i.e., type I (oxygen independent) and type II (oxygen dependent), respectively, and results in significantly enhanced destruction of tumor cells. The preliminary in vitro and in vivo results in a PC3 cell line and tumor model indicate that the tumor specificality of the therapeutic agent(s) can be increased by targeting galectin-1 and galectin-3, known for their overexpression in prostate cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- PDT Center, Cell Stress Biology, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263, USA.
- Department of Urology, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263, USA.
Förderung
- NCI NIH HHS
- RPCCC Support Grant
- Photolitec, LLC
Zitieren
APA
Cacaccio, J., Durrani, F. A., Kumar, I., Dukh, M., Camacho, S., Fayazi, Z., Sumlin, A., Kauffman, E., Guru, K., & Pandey, R. K. (2023). Excitation of a Single Compound by Light and Ultrasound Enhanced the Long-Term Cure of Mice Bearing Prostate Tumors. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms241310624
Vancouver
Cacaccio J, Durrani FA, Kumar I, Dukh M, Camacho S, Fayazi Z, et al. Excitation of a Single Compound by Light and Ultrasound Enhanced the Long-Term Cure of Mice Bearing Prostate Tumors. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms241310624
BibTeX
@article{Cacaccio2023,
author = {Cacaccio, Joseph and Durrani, Farukh A and Kumar, Ishaan and Dukh, Mykhaylo and Camacho, Susan and Fayazi, Zahra and Sumlin, Adam and Kauffman, Eric and Guru, Khurshid and Pandey, Ravindra K},
title = {Excitation of a Single Compound by Light and Ultrasound Enhanced the Long-Term Cure of Mice Bearing Prostate Tumors},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms241310624}
}
EUVIMED